Why are these marketplaces still observed as engaging places to offer drugs, despite the risks? To discover, our current study surveyed thirteen darknet drug suppliers, through online encrypted interviews. They gave us A selection of explanations.In MAPS’s scenario, the health practitioner concerned is Dr. Michael Mithoefer, a psychiatrist based